Literature DB >> 19455059

Transient life-threatening cerebral edema in a patient with systemic lupus erythematosus.

Matt T Bianchi1, Catherine Lavigne, Farzaneh Sorond, Bonnie Bermas.   

Abstract

Central nervous system symptoms occur in a substantial portion of patients with systemic lupus erythematosus. However, coma is a rare presentation and is usually secondary to complications such as subarachnoid hemorrhage, seizure, or ischemia. Here, we present a 49-year-old woman with lupus erythematosus and a history of recurrent aseptic meningitis and mild subarachnoid hemorrhage who presented with altered mental status and lethargy that progressed rapidly over hours to the herniation syndrome of coma, extensor posturing, and unilateral pupillary dilation. Spinal fluid showed massive protein elevation (>1600), and head computed tomography revealed global cerebral edema. The clinical and radiologic findings rapidly reversed with intravenous corticosteroids and mannitol within 24 hours, and her mental status improved to baseline. Her course was complicated by 2 episodes of recurrent encephalopathy when corticosteroids were tapered; these resolved after resuming high dosing. Because of ongoing pancytopenia, chemotherapy immunosuppression was delayed, and instead she received intravenous immunoglobulin with improvement in the pancytopenia. She remained cognitively intact during subsequent corticosteroid tapering. Rapid development of coma in lupus patients may be due to a primary process of the disease impacting blood brain barrier integrity. Although rare, this potentially fatal complication may be reversible with acute corticosteroid administration.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19455059      PMCID: PMC4419698          DOI: 10.1097/RHU.0b013e3181a64e9c

Source DB:  PubMed          Journal:  J Clin Rheumatol        ISSN: 1076-1608            Impact factor:   3.517


  30 in total

Review 1.  Junctional complexes of the blood-brain barrier: permeability changes in neuroinflammation.

Authors:  Margaret A Petty; Eng H Lo
Journal:  Prog Neurobiol       Date:  2002-12       Impact factor: 11.685

Review 2.  Regulation of brain aquaporins.

Authors:  E Gunnarson; M Zelenina; A Aperia
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

Review 3.  The blood-brain barrier in neuroinflammatory diseases.

Authors:  H E de Vries; J Kuiper; A G de Boer; T J Van Berkel; D D Breimer
Journal:  Pharmacol Rev       Date:  1997-06       Impact factor: 25.468

4.  A case of diffuse lupus encephalopathy successfully treated with high-dose intravenous methylprednisolone.

Authors:  G Di Iorio; U Picillo; P Santanelli; S Migliaresi; V Bonavita
Journal:  Ital J Neurol Sci       Date:  1992-04

Review 5.  The central nervous system in systemic lupus erythematosus. Part 2. Pathogenetic mechanisms of clinical syndromes: a literature investigation.

Authors:  F G I Jennekens; L Kater
Journal:  Rheumatology (Oxford)       Date:  2002-06       Impact factor: 7.580

Review 6.  The central nervous system in systemic lupus erythematosus. Part 1. Clinical syndromes: a literature investigation.

Authors:  F G I Jennekens; L Kater
Journal:  Rheumatology (Oxford)       Date:  2002-06       Impact factor: 7.580

7.  Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance.

Authors:  John G Hanly; Grace McCurdy; Lisa Fougere; Jo-Anne Douglas; Kara Thompson
Journal:  J Rheumatol       Date:  2004-11       Impact factor: 4.666

8.  Neuropsychiatric syndromes in lupus: prevalence using standardized definitions.

Authors:  R L Brey; S L Holliday; A R Saklad; M G Navarrete; D Hermosillo-Romo; C L Stallworth; C R Valdez; A Escalante; I del Rincón; G Gronseth; C B Rhine; P Padilla; D McGlasson
Journal:  Neurology       Date:  2002-04-23       Impact factor: 9.910

9.  Response of acute cerebral lupus in childhood to pulse methylprednisolone in reduced dosage.

Authors:  O Hanmer; D Saltissi
Journal:  Ann Rheum Dis       Date:  1986-07       Impact factor: 19.103

10.  The diversity of neurologic events in systemic lupus erythematosus. Prospective clinical and computed tomographic classification of 82 events in 71 patients.

Authors:  A T Kaell; M Shetty; B C Lee; M D Lockshin
Journal:  Arch Neurol       Date:  1986-03
View more
  2 in total

Review 1.  Indications for IVIG in rheumatic diseases.

Authors:  Ben Mulhearn; Ian N Bruce
Journal:  Rheumatology (Oxford)       Date:  2014-11-17       Impact factor: 7.580

2.  Leukoencephalopathy and cerebral edema as the presenting manifestations of SLE in an ANA-negative adolescent female: a case report and review of literature.

Authors:  Alexandra Theisen; Paroma Bose; Christina Knight; Melissa Oliver
Journal:  Pediatr Rheumatol Online J       Date:  2020-07-13       Impact factor: 3.054

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.